At the end of Q3 2024, shares of Tilray Brands, Inc. (NASDAQ:TLRY) were held by 16 hedge funds in the IM database with a total stake value of $20.62 million, up 36% from the previous quarter.
Medical announced the expansion of its medical cannabis extract portfolio in Germany. Tilray’s new medical cannabis offerings in ...
Tilray cultivates a wide range of strains to meet patient needs including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: extracts and dried ...
Budweiser (NYSE: BUD) entered a joint venture to develop non-alcoholic CBD drinks with Tilray Inc. (NASDAQ: TLRY). You can still catch up with the market trend and gain some good earnings by ...
Tilray Brands Inc.’s stock fell Friday after the beer and cannabis company said it expects a $20 million impact on its full-year revenue as it embarks on a cost-cutting plan that will reduce the ...
We recently published a list of 7 Best CBD Stocks To Invest In Right Now. In this article, we are going to take a look at where Tilray Brands, Inc. (NASDAQ:TLRY) stands against other best CBD stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results